[1] P. Strandwitz et al., "GABA-modulating bacteria of the human gut microbiota," Nature Microbiology, vol. 4, pp. 396–403, 2019.
[2] J. F. Cryan and T. G. Dinan, "Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour," Nature Reviews Neuroscience, vol. 13, pp. 701–712, 2012.
[3] P. Ataei, H. Kalantari, T. S. Bodnar, and R. J. Turner, "The gut–brain connection: microbes' influence on mental health and psychological disorders," Frontiers in Microbiomes, vol. 4, Art. no. 1701608, 2026, doi: 10.3389/frmbi.2025.1701608.
[4] C. Cheng et al., "Insomnia treatment based on the regulation of the GABAergic system: traditional Chinese medicine perspectives and therapeutic approaches," Frontiers in Neuroscience, 2025, doi: 10.3389/fnins.2025.1670273.
[5] J. V. Andersen and A. Schousboe, "Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration," Journal of Neurochemistry, 2023, doi: 10.1111/jnc.15811.
[6] X. Li et al., "Progress in research on the mechanism of GABA in improving sleep," Foods, vol. 14, no. 22, p. 3856, 2025, doi: 10.3390/foods14223856.
[7] E. Sallard, D. Letourneur, and P. Legendre, "Electrophysiology of ionotropic GABA receptors," Cellular and Molecular Life Sciences, vol. 78, no. 13, pp. 5341–5370, 2021, doi: 10.1007/s00018-021-03846-2.
[8] C. Jiang, Y. Chen, and T. Sun, "From the gut to the brain, mechanisms and clinical applications of γ-aminobutyric acid (GABA) on the treatment of anxiety and insomnia," Frontiers in Neuroscience, 2025, doi: 10.3389/fnins.2025.1570173.
[9] D.-P. Li and H.-L. Pan, "Role of γ-aminobutyric acid (GABA)A and GABAB receptors in paraventricular nucleus in control of sympathetic vasomotor tone in hypertension," Journal of Pharmacology and Experimental Therapeutics, vol. 320, no. 2, pp. 615–626, 2007, doi: 10.1124/jpet.106.109538.
[10] Q. Zhu et al., "GABA and its receptors' mechanisms in the treatment of insomnia," Heliyon, 2024, doi: 10.1016/j.heliyon.2024.e40665.
[11] E. Sezgin and B. Tekin, "Molecular evolution and population genetics of glutamate decarboxylase acid resistance pathway in lactic acid bacteria," Frontiers in Genetics, 2023, doi: 10.3389/fgene.2023.1027156.
[12] I. B. A. Yogeswara, S. Maneerat, and D. Haltrich, "Glutamate decarboxylase activity of lactic acid bacteria and gamma-aminobutyric acid production," Microorganisms, vol. 8, no. 12, p. 1923, 2020, doi: 10.3390/microorganisms8121923.
[13] R. Dhakal, V. K. Bajpai, and K.-H. Baek, "Production of GABA (γ-aminobutyric acid) by microorganisms: a review," Brazilian Journal of Microbiology, 2012, doi: 10.1590/s1517-83822012000400001.
[14] A. P. Allen, W. Hutch, Y. E. Borre, and P. Kennedy, "Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers," Translational Psychiatry, 2016.
[15] H. Wang, C. Braun, E. F. Murphy, and P. Enck, "Bifidobacterium longum 1714 strain modulates brain activity of healthy volunteers during social stress," American Journal of Gastroenterology, 2019, doi: 10.14309/ajg.0000000000000203.
[16] L. C. Lew, Y. Y. Hor, J. Jaafar et al., "Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults," Clinical Nutrition, 2019, doi: 10.1016/j.clnu.2018.09.010.
[17] H. Mruk-Mazurkiewicz, M. Kulaszyńska, W. Czarnecka, A. Podkówka, N. Ekstedt, P. Zawodny, A. Wierzbicka-Woś, W. Marlicz, B. Skupin, E. Stachowska, et al., "Insights into the mechanisms of action of Akkermansia muciniphila in the treatment of non-communicable diseases," Nutrients, vol. 16, no. 11, p. 1695, 2024, doi: 10.3390/nu16111695.
[18] Y. Xu and Y. Zhang, "The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential," Critical Reviews in Microbiology, 2023, doi: 10.1080/1040841X.2022.2044286.
[19] X. Yuan, L. Shi et al., "Akkermansia muciniphila: a next generation gut probiotic supporting neurorepair and functional recovery," 2025.
[20] W. Zhang, L. Wang et al., "Potential of Akkermansia muciniphila and its outer membrane proteins as therapeutic targets for neuropsychological diseases," Frontiers in Microbiology, 2023, doi: 10.3389/fmicb.2023.1191445.
[21] J. Ye, H. Cai et al., "Akkermansia muciniphila: a microbial guardian against oxidative stress-gut microbiota crosstalk and clinical prospects," Journal of Translational Medicine, 2025, doi: 10.1186/s12967-025-07149-z.
[22] C. Feehily and A. K. Karatzas, "Role of glutamate metabolism in bacterial responses towards acid and other stresses," Journal of Applied Microbiology, vol. 114, no. 1, pp. 11–24, 2013, doi: 10.1111/j.1365-2672.2012.05434.x.
[23] K. E. Quillin et al., "GABA as a metabolite and signaling molecule in bacterial communities," 2021, doi: 10.1089/bioe.2021.0012.
[24] N. Otaru, A. Krzystek, T. de Wouters, C. Braegger, C. Lacroix, and B. Pugin, "GABA production by human intestinal Bacteroides spp.," Frontiers in Microbiology, 2021, doi: 10.3389/fmicb.2021.656895.
[25] R. M. Stilling, M. van de Wouw, G. Clarke, C. Stanton, T. G. Dinan, and J. F. Cryan, "The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?," Neurochemistry International, 2016, doi: 10.1016/j.neuint.2016.06.011.
[26] A. Mhanna et al., "The correlation between gut microbiota and both neurotransmitters and mental disorders: a narrative review," Medicine (Baltimore), 2024, doi: 10.1097/MD.0000000000037114.
[27] M. Valles-Colomer et al., "The neuroactive potential of the human gut microbiota in quality of life and depression," Nature Microbiology, 2019, doi: 10.1038/s41564-018-0337-x.
[28] J. D. Braga, M. Thongngam, and T. Kumrungsee, "Gamma-aminobutyric acid as a potential postbiotic mediator in the gut-brain axis," NPJ Science of Food, 2024, doi: 10.1038/s41538-024-00253-2.
[29] B. W. Logsdon et al., "Gut reactions: how the blood-brain barrier connects the microbiome and the brain," Experimental Biology and Medicine, 2018.
[30] K. A. Conn, E. M. Borsom, and E. K. Cope, "Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer's disease," Gut Microbes, vol. 16, no. 1, p. 2371950, 2024, doi: 10.1080/19490976.2024.2371950.
[31] S. Breit, A. Kupferberg, G. Rogler, and G. Hasler, "Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders," Frontiers in Neuroscience, 2018, doi: 10.3389/fnins.2018.00049.
[32] Y. Li, Y. Hao, F. Fan, and B. Zhang, "The role of microbiome in insomnia, circadian disturbance and depression," Frontiers in Psychiatry, vol. 9, p. 669, 2018, doi: 10.3389/fpsyt.2018.00669.
[33] D. Belelli, J. J. Lambert, M. L. Y. Wan, A. R. Monteiro, D. J. Nutt, and J. D. Swinny, "From bugs to brain: unravelling the GABA signalling networks in the brain-gut-microbiome axis," Brain, vol. 148, no. 5, pp. 1479–1506, 2025, doi: 10.1093/brain/awae413.
[34] J. A. Foster and K. M. Neufeld, "Gut-brain axis: how the microbiome influences anxiety and depression," Trends in Neurosciences, 2013.
[35] M. A. Icer et al., "Contributions of gamma-aminobutyric acid (GABA) produced by lactic acid bacteria on food quality and human health: current applications and future prospects," Foods, vol. 13, no. 15, p. 2437, 2024, doi: 10.3390/foods13152437.
[36] G. R. Gibson et al., "Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics," Nature Reviews Gastroenterology & Hepatology, 2017.
[37] B. Dalile, L. Van Oudenhove, B. Vervliet, and K. Verbeke, "The role of short-chain fatty acids in microbiota-gut-brain communication," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 8, pp. 461–478, 2019, doi: 10.1038/s41575-019-0157-3.
[38] M. C. Rodríguez-Daza, E. C. Pulido-Mateos, J. Lupien-Meilleur, D. Guyonnet, Y. Desjardins, and D. Roy, "Polyphenol-mediated gut microbiota modulation: toward prebiotics and further," Frontiers in Nutrition, 2021, doi: 10.3389/fnut.2021.689456.
[39] R. J. S. Gerritsen and G. P. H. Band, "Breath of life: the respiratory vagal stimulation model of contemplative activity," Frontiers in Human Neuroscience, vol. 12, p. 397, 2018, doi: 10.3389/fnhum.2018.00397.
[40] S. Laborde et al., "Vagal tank theory and the role of slow-paced breathing in the regulation of the autonomic nervous system," Neuroscience & Biobehavioral Reviews, 2022, doi: 10.1016/j.neubiorev.2022.104711.
[41] V. Monda et al., "Exercise modifies the gut microbiota with positive health effects," Oxidative Medicine and Cellular Longevity, vol. 2017, p. 3831972, 2017, doi: 10.1155/2017/3831972.
[42] J. M. A. Cullen, S. Shahzad, and J. Dhillon, "A systematic review on the effects of exercise on gut microbial diversity, composition, and microbial metabolites: identifying research gaps and future directions," Frontiers in Physiology, 2023, doi: 10.3389/fphys.2023.1292673.
[43] T. Song, P. T. Morgan, F. Muench, Y. Li, and J. Shen, "Sleep and brain GABA levels," Sleep Medicine, 2020, doi: 10.1016/j.sleep.2020.02.002.
[44] P. T. Morgan et al., "Sleep deprivation and brain GABA levels in healthy adults," 2008.
[45] E. Boonstra et al., "Neurotransmitters as food supplements: the effects of GABA on brain and behavior," Frontiers in Psychology, vol. 6, p. 1520, 2015.
[46] J. A. Bravo et al., "Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve," Proceedings of the National Academy of Sciences, 2011, doi: 10.1073/pnas.1102999108.
[47] N. Ottman et al., "Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function," 2017.
[48] M. Konstanti and C. Belzer, "GABA production by Akkermansia muciniphila is condition-dependent," Applied and Environmental Microbiology, 2024, doi: 10.1128/aem.01121-23.
[49] K. M. Bendtsen et al., "The role of the gut microbiota in personalized health and disease," 2019, doi: 10.1017/S0140525X1800287X.
[50] K. Skonieczna-Żydecka et al., "Microbiota-gut-brain axis and the central nervous system: the role of inflammatory Proteobacteria and endotoxins in neuropsychiatric disorders," International Journal of Molecular Sciences, 2022, doi: 10.3390/ijms231911642.
[51] Y. N. Ramadan et al., "Microbiome gut-brain-axis: impact on brain development and mental health," Molecular Neurobiology, vol. 62, no. 8, pp. 10813–10833, 2025, doi: 10.1007/s12035-025-04846-0.
[52] R. Ranjan et al., "Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing," 2016.